Anti-DNA Topoisomerase IIα Autoantibodies in Localized Scleroderma

Arthritis and Rheumatism

Volumn 50, Issue 1, 2004, Pages 227-232

  Hayakawa, Ikuko ^a   Hasegawa, Minoru ^a   Takehara, Kazuhiko ^a   Sato, Shinichi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DERMATOMYOSITIS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NEOPLASM; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; SEROEPIDEMIOLOGIC STUDIES;

EID: 0345827473     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11432     Document Type: Article

References (15)

1. Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993;36:1137-41.
2. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 1994;130:1273-7.
3. Grigolo B, Mazzetti I, Borzi RM, Hickson ID, Fabbri M, Fasano L, et al. Mapping of topoisomerase II α epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis. Clin Exp Immunol 1998;114:339-46.
4. Meliconi R, Bestagno M, Sturani C, Negri C, Galavotti V, Sala C, et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol 1989;76:184-9.
5. Grigolo B, Mazzetti I, Meliconi R, Bazzi S, Scorza R, Candela M, et al. Anti-topoisomerase II α autoantibodies in systemic sclerosis: association with pulmonary hypertension and HLA-B35. Clin Exp Immunol 2000;121:539-43.
6. Chang YH, Hwang J, Shang HF, Tsai ST. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes 1996;45:408-14.
7. Zuklys KL, Szer IS, Szer W. Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis. Clin Exp Immunol 1991;84: 245-9.
8. Hoffmann A, Heck MM, Bordwell BJ, Rothfield NF, Earnshaw WC. Human autoantibody to topoisomerase II. Exp Cell Res 1989;180:409-18.
9. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
13. Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1996;184:765-70.
14. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996;98:785-92.
15. McKeon FD, Tuffanelli DL, Fukuyama K, Kirschner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci U S A 1983;80:4374-8.